Bristol Myers Squibb (BMY) Friday said it appointed Cristian Massacesi as Executive Vice President, Chief Medical Officer, and Head of Development, effective August 1, 2025.
Massacesi succeeds Samit Hirawat, who is stepping down to pursue new opportunities.
Massacesi having more than 20 years of biopharmaceutical experience, most recently served as Chief Medical Officer of AstraZeneca and Alexion and as Oncology Chief Development Officer at AstraZeneca.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.